From Patricia Karani, HAE Kenya

Giving a Voice to Patients Living with Hereditary Angioedema in Kenya

For many people in Kenya living with Hereditary Angioedema (HAE), the journey to diagnosis and appropriate care remains long, confusing, and often isolating. Between October and December 2025, HAE Kenya intensified its advocacy efforts to ensure that patients are not only seen within the healthcare system but heard, understood, and supported.

A significant step toward patient empowerment during this period was the completion of the Understanding HAE booklet in the Swahili language. As Kenya’s national language, Swahili plays a critical role in reaching out to a larger audience of patients and families, especially in areas where Swahili is more conversant than English. By making HAE education accessible in a familiar language, HAE Kenya is helping patients better understand their condition, advocate for themselves in clinical settings, and engage more confidently in their care—particularly in rural and underserved communities.

Recognizing that awareness must be matched with access, HAE Kenya also updated its website to serve as a practical resource for patients seeking care. The platform now includes up-to-date information and a growing list of healthcare professionals trained in HAE diagnosis and management across the country. For patients living far from the ACARE Centre based in Nairobi, this has been a critical development, offering reassurance that knowledgeable medical support can be found closer to home and reducing the burden of long-distance travel for already vulnerable families.

Advocacy efforts extended directly into healthcare facilities through a collaborative awareness initiative with Dr. Priya Bowry of the ACARE Centre at the Coast General Teaching and Referral Hospital in Mombasa. The session brought together doctors, nurses, medical students, and pathologists, creating a vital space for dialogue between clinicians and the patient community. Central to this engagement was the sharing of a patient journey to diagnosis—an experience that illuminated the real consequences of delayed recognition, misdiagnosis, and limited treatment options. By centering the patient voice, the discussion challenged healthcare providers to consider not only the clinical presentation of HAE but its profound impact on quality of life, mental well-being, and family dynamics.

Healthcare professionals were encouraged to maintain a high index of suspicion for HAE and to view early diagnosis as a form of patient advocacy in itself. The visibility of HAE Emergency Department posters displayed within the hospital further reinforced this message, serving as a constant reminder that rare diseases, though often overlooked, require readiness and informed response.

Beyond awareness, HAE Kenya continued to support newly identified patients and their families by facilitating appropriate referrals through the ACARE Centre. For many, this marked a turning point—ending years of uncertainty and opening a pathway to effective treatment and informed care. The gratitude expressed by families underscored a simple but powerful truth: access to the right care can transform lives.

These efforts reflect HAE Kenya’s broader advocacy mission—to build a healthcare environment where rare disease patients are not marginalized, where language and geography do not determine outcomes, and where patient voices help shape systems of care. While challenges remain, the progress made during this period affirms that sustained advocacy, partnership, and patient leadership are essential to improving the lives of those living with Hereditary Angioedema in Kenya.